Target intelligence / Profile preview

Virus surface protein

Molecular classification
Other (Viral structural protein), Other (Fusion protein), Other (Envelope protein), Other (Glycoprotein)
01

Overview

Virus surface proteins refer collectively to a diverse group of structural and functional proteins situated on the exterior of viruses, including glycoproteins, envelope proteins, fusion proteins, and spike proteins[3][4][9]. These proteins mediate essential steps in the viral life cycle, primarily enabling attachment to and entry into host cells by binding to specific cellular receptors and/or mediating membrane fusion[3][4][6][7]. Major classes of viral surface proteins include class I, II, III, and IV fusion proteins, differing in structure and mechanism but sharing the role of driving entry into host cells[3][4][7]. Virus surface proteins are frequent targets for antiviral drug development and neutralizing antibodies in vaccines[3][4]. The term "virus surface proteins" does not specify a single molecule, but rather encompasses a heterogeneous family of proteins with varied sequence, structure, and function across different virus taxa, such as the spike (S) protein of coronaviruses, hemagglutinin (HA) of influenza, gp120/gp41 of HIV, and glycoprotein (GP) of filoviruses.

Other names
Virus envelope proteinViral glycoproteinViral fusion proteinViral spike proteinEnvelope glycoprotein
02

Mechanism of action

Inhibition of viral entry, Blockade of receptor binding, Disruption of membrane fusion

03

Biological functions

Host cell recognitionAttachment to host cellEntry into host cellFusion of viral and cellular membranesImmune evasion
04

Disease associations

InfectionOther (Viral disease)
05

Safety considerations

Antigenic variability and immune escapePotential for allergy and adverse reactions with protein-based therapies or vaccinesOff-target effects if host and viral surface proteins share homology
06

Interacting drugs

Enfuvirtide

4 more in the full profile.

07

Biomarkers

Presence or level of viral surface proteins (e.g., Spike protein for SARS-CoV-2 PCR/antibody diagnostics)Glycoprotein expression (Ebola, Influenza)

Beyond the preview

Go deeper on Virus surface protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Virus surface protein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call